Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2021 08:00 ET | Source: Conformis, Inc.

Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021

BILLERICA, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the fourth quarter and fiscal year ended December...
December 31, 2020 08:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in Upcoming Investor Conferences

BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief...
December 17, 2020 16:15 ET | Source: Conformis, Inc.

Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System

BILLERICA, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today the U.S. commercial launch of the Company’s new Cordera™ Match Hip System. The Company previously...
November 24, 2020 16:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference

BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
November 09, 2020 16:30 ET | Source: Conformis, Inc.

Conformis Announces Bart Lagae as VP, International Sales & Marketing; Inducement Grant Reported

BILLERICA, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Bart Lagae as its new VP, International Sales & Marketing. “We...
November 04, 2020 16:10 ET | Source: Conformis, Inc.

Conformis Reports Third Quarter 2020 Financial Results

BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Summary Total...
October 28, 2020 18:30 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit

BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
October 06, 2020 07:30 ET | Source: Conformis, Inc.

Conformis Reports Preliminary Third Quarter Revenue Results

BILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected...
September 29, 2020 10:45 ET | Source: Conformis, Inc.

Conformis Announces 510(k) Clearance for Cordera™ Hip System

BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip...
September 24, 2020 07:00 ET | Source: Conformis, Inc.

Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market

BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to...